Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
St. Vincent’s Hospital in Melbourne is first health system in Australia to adopt robotic-assisted microsurgery with Symani
MMI’s Symani® Surgical System Named a TIME Best Invention of 2024
Patient story highlights new possibilities in breast cancer-related lymphedema with the help of robotic-assisted microsurgery
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Symani is manufactured in Pisa, Italy.
Clinical indications vary by geography. Refer to global indications for more information.
© 2025 Medical Microinstruments, Inc. All Rights Reserved.




